Natco Pharma Proposes Rights Issue of up to ₹13,000 Million

Natco Pharma Ltd has announced its proposal to undertake a Rights Issue of Equity Shares, subject to regulatory approvals. The issue aims to raise up to ₹13,000 million by offering fully paid-up equity shares of face value ₹2 each at a price of ₹[●] per share. The ratio for the rights entitlement is [●] rights equity shares for every [●] fully paid-up equity shares held on the record date, which is set for [●]. The company has provided a draft letter of offer detailing the terms and risks associated with this issue. Investors are advised to carefully review the risk factors before making any investment decisions.